Experimental Endamoeba Histolytica Infections in Rabbits with Reference to Chemotherapy

George W. LuttermoserNational Institutes of Health, National Microbiological Institute, Laboratory of Tropical Diseases, Bethesda 14, Maryland

Search for other papers by George W. Luttermoser in
Current site
Google Scholar
PubMed
Close
,
W. T. HaskinsNational Institutes of Health, National Microbiological Institute, Laboratory of Tropical Diseases, Bethesda 14, Maryland

Search for other papers by W. T. Haskins in
Current site
Google Scholar
PubMed
Close
,
Nell ColemanNational Institutes of Health, National Microbiological Institute, Laboratory of Tropical Diseases, Bethesda 14, Maryland

Search for other papers by Nell Coleman in
Current site
Google Scholar
PubMed
Close
, and
J. R. JumperNational Institutes of Health, National Microbiological Institute, Laboratory of Tropical Diseases, Bethesda 14, Maryland

Search for other papers by J. R. Jumper in
Current site
Google Scholar
PubMed
Close
Restricted access

Experimental infections of Endamoeba histolytica have been established in several laboratory animals, many of which have been utilized in chemotherapeutic studies. Jones (1948) ably reviewed the history of the infection of dogs, cats, and monkeys with E. histolytica and stated that “such valuable amebicides as stovarsol, carbarsone, Vioform, and Diodoquin have resulted.” Anderson et al. (1947, 1950) have further shown the activity of some thioarsenites and antibiotics against natural amebic infection in the monkey. The suitability of the dog as a test animal was studied critically by Thompson et al. (1949, 1950) who reported a satisfactory correlation between the response of canine and human amebiasis and stated that the dog should be particularly useful in the search for new chemotherapeutic agents. Clampit (1948) found that some cases of acute fulminating amebiasis produced experimentally in the kitten were cured by the use of Vioform, chiniofon, and carbarsone but none were cured by emetine.

Save